Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-2.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-145.53%
202439.96%
202326.42%
20227.52%
2021-1.91%
202049.61%
2019211.70%
201883.23%
20173.19%
2016-326.90%